Families across the country are pursuing lawsuits alleging that using Tylenol or another acetaminophen-containing medication during pregnancy contributed to a child developing autism spectrum disorder or attention-deficit/hyperactivity disorder. The scientific and legal questions remain contested. However, a July 13, 2026 federal appellate decision revived more than 500 lawsuits and allowed the plaintiffs to continue relying on testimony from three general-causation experts. The decision did not establish that acetaminophen causes autism or ADHD, but it placed the litigation back on track. If you used acetaminophen during pregnancy and your child was later diagnosed with autism or ADHD, Altman Nussbaum Shunnarah Trial Attorneys can review your family’s circumstances and explain your legal options.
Request a Free Case Evaluation
Quick Answer
Tylenol autism and ADHD lawsuits claim that exposure to acetaminophen during pregnancy contributed to children developing autism spectrum disorder, attention-deficit/hyperactivity disorder, and/or other neurodivergent conditions.
Plaintiffs claim that manufacturers and retailers of acetaminophen failed to adequately warn consumers about these potential neurodevelopmental risks associated with taking Tylenol during pregnancy.
On July 13, 2026, the Second Circuit federal appeals court reversed a past court’s decision that had effectively ended the lawsuit before it ever started. This ruling reversed the exclusion of the plaintiffs’ main experts and gave life to more than 500 federal claims.
This ruling has allowed the litigation to continue, but it does not prove that acetaminophen/Tylenol causes autism or ADHD, nor does it guarantee that anyone will have a successful claim. Instead, it allows the case to continue so that both sides can present evidence and experts, and the plaintiffs can have their day in court.
If you are interested in filing a claim, you should speak to an attorney who can evaluate your potential case based on prenatal acetaminophen exposure, your or your child’s diagnosis, available evidence, state laws, and other relevant factors.
Could Tylenol During Pregnancy Play a Role in Autism or ADHD?
Short Answer: Some observational studies have reported an association between prenatal acetaminophen exposure and autism, ADHD, or other neurodevelopmental outcomes. However, an association does not establish that acetaminophen caused the condition, and the scientific community has not reached a consensus that prenatal acetaminophen exposure causes autism or ADHD. The research is mixed. A 2021 consensus statement called for precautionary use during pregnancy, while a large 2024 sibling-control study found no association after researchers accounted more fully for shared familial factors. The FDA stated in September 2025 that evidence suggested a possible association and began a process intended to revise acetaminophen labeling, but it also acknowledged that a causal relationship had not been established.
Key Takeaways
- Multiple observational studies have reported associations between prenatal acetaminophen exposure and autism or ADHD.
- Observational findings do not prove that acetaminophen caused a child’s diagnosis.
- Genetics, maternal illness, fever, the reason acetaminophen was taken, and other factors may influence study results.
- Some researchers believe the evidence justifies greater precaution and clearer warnings.
- Other researchers and medical organizations maintain that the available evidence does not establish causation.
- The Second Circuit’s July 2026 ruling addressed the admissibility of expert testimony, not whether acetaminophen actually causes autism or ADHD.
- Families should discuss medication decisions during pregnancy with a qualified healthcare provider. The bottom line is that there is evidence of a possible association, but causation remains disputed and has not been established as fact.
Quick Facts About the Tylenol Autism and ADHD Litigation
- Medication involved: Tylenol and other medications containing acetaminophen.
- Alleged conditions: Autism spectrum disorder and attention-deficit/hyperactivity disorder.
- Primary legal theory: Failure to provide adequate warnings about potential risks associated with prenatal acetaminophen exposure.
- Defendants: The litigation has included claims against Tylenol manufacturers and major retailers that sold store-brand acetaminophen products.
- Current status: More than 500 federal lawsuits were revived by the Second Circuit on July 13, 2026.
- Meaning of the appellate ruling: Three plaintiffs’ general-causation experts may remain in the litigation, subject to further proceedings and challenges.
- What the ruling did not decide: The court did not find that acetaminophen causes autism or ADHD.
- Existing settlements: There is no announced global settlement resolving the Tylenol autism and ADHD litigation.
- Cost to speak with ANS: Initial case evaluations are free. These are the central facts. To understand how the litigation began, it helps to look more closely at what families are alleging.
Why Are Families Filing Tylenol Autism and ADHD Lawsuits?
Short Answer: Families are filing lawsuits because they allege that manufacturers and retailers failed to adequately warn pregnant consumers about research examining a possible association between prenatal acetaminophen exposure and autism or ADHD. The defendants dispute those allegations and maintain that credible scientific evidence has not established a causal connection. For decades, acetaminophen has been one of the most commonly used medications for treating pain and fever during pregnancy. Many expectant mothers relied on Tylenol because other common pain relievers may present recognized risks during particular stages of pregnancy. The lawsuits allege that pregnant consumers were not given adequate information about a growing body of research examining whether prenatal exposure to acetaminophen might be associated with neurodevelopmental conditions.
Failure-to-Warn Claims
Most of these lawsuits focus on an alleged failure to warn. A product liability warning claim generally asks whether a manufacturer or seller knew or should have known about a material risk and whether the product included an adequate warning addressing that risk. Plaintiffs contend that manufacturers and retailers had access to scientific literature raising concerns about prenatal acetaminophen exposure but continued selling the medication without adequately informing pregnant consumers. According to the plaintiffs, an appropriate warning would have allowed patients and their healthcare providers to weigh the possible risks and benefits more fully. It could also have encouraged pregnant consumers to use acetaminophen only when medically necessary, at the lowest effective dose, and for the shortest appropriate period.
The Defendants Dispute the Allegations
The companies involved deny that the evidence establishes a causal relationship between acetaminophen use during pregnancy and autism or ADHD. Kenvue, the current maker of Tylenol, maintains that the medication is safe when used as directed and that independent science does not prove a link between prenatal acetaminophen exposure and autism or ADHD. The company has indicated that it intends to continue challenging the reliability and conclusions of the plaintiffs’ experts. Other medical researchers have also questioned whether reported associations are explained by factors such as genetics, maternal illness, fever, family medical history, or the underlying reason the medication was taken.
What the Lawsuits Are Not Claiming
The lawsuits do not allege that every child exposed to acetaminophen during pregnancy will develop autism or ADHD. They also do not establish that every use of acetaminophen during pregnancy was medically inappropriate. Untreated pain and fever can carry risks of their own, and pregnant patients should not stop or change medication use based solely on information contained on a legal website. The central legal allegation is narrower: plaintiffs claim that consumers should have received more information about potential neurodevelopmental risks so they could make informed decisions with their healthcare providers. If you used Tylenol during pregnancy and your child was later diagnosed with autism or ADHD, ANS can review the circumstances and determine whether further investigation may be appropriate. The consultation is free, and you are not required to pursue a claim simply because you speak with an attorney. That leads to the question at the center of these cases: what does the scientific research actually show?
What Does the Research Say About Tylenol, Autism, and ADHD?
Short Answer: Scientific studies have produced mixed findings. Several observational studies have reported an association between prenatal acetaminophen exposure and autism, ADHD, or other neurodevelopmental outcomes, while stronger designs intended to account for familial and genetic factors have found that the apparent association may not be causal. That distinction matters. Research can identify a statistical relationship without proving that one factor caused the other.
Observational Studies Have Reported Associations
Researchers cannot ethically assign pregnant participants to take potentially harmful medication merely to measure long-term outcomes. As a result, much of the research is observational. These studies may examine:
- Medication use reported during pregnancy
- Prescription or medical records
- Umbilical cord biomarkers
- Duration or frequency of exposure
- Childhood diagnoses and developmental outcomes
Several observational studies have found that children with greater prenatal acetaminophen exposure were more frequently diagnosed with autism, ADHD, language delays, or related neurodevelopmental conditions. Some studies have also reported a dose-response pattern, meaning that longer or more frequent exposure appeared to correspond with a greater observed risk. Such patterns can support a causal hypothesis, but they do not eliminate alternative explanations.
Association Is Not the Same as Causation
A study showing that two events occur together does not necessarily prove that one caused the other. Researchers must account for confounding factors. These are variables connected to both acetaminophen use and childhood neurodevelopment that could create or exaggerate an apparent association. Potential confounding factors include:
- Maternal fever or infection
- Chronic pain or inflammatory conditions
- Genetics
- Family history of autism or ADHD
- Other medications
- Environmental exposures
- Maternal age
- Pregnancy complications
- The medical reason acetaminophen was taken
Researchers refer to this as confounding by indication. In other words, the condition that led someone to take acetaminophen may be connected to the child’s outcome even if the medication itself was not the cause.
The 2021 Consensus Statement Called for Precaution
In 2021, a group of scientists, clinicians, and public health professionals published a consensus statement in Nature Reviews Endocrinology. The authors reviewed experimental and epidemiological evidence and recommended precautionary steps. These included using acetaminophen during pregnancy only when medically indicated, consulting a physician or pharmacist before long-term use, and using the lowest effective dose for the shortest necessary duration. The statement did not conclude that acetaminophen had been definitively proven to cause autism or ADHD. It argued that the available evidence was sufficient to justify greater caution and additional research. The American College of Obstetricians and Gynecologists responded that the evidence available at the time did not demonstrate a direct relationship between prudent acetaminophen use during pregnancy and fetal developmental problems.
A Major 2024 Study Found No Association in Sibling Comparisons
A 2024 nationwide Swedish study examined nearly 2.5 million children and initially observed small associations between acetaminophen exposure during pregnancy and autism, ADHD, or intellectual disability. Those associations disappeared in sibling-control analyses. This research design compared siblings who shared genetics and many environmental factors but had different documented prenatal exposures. The authors concluded that prenatal acetaminophen use was not associated with autism, ADHD, or intellectual disability in the sibling-control analysis. They stated that associations found in less-controlled models may have resulted from familial confounding. The study matters because sibling comparisons can account for some shared genetic and environmental factors that conventional observational studies may miss.
The FDA Addressed a Possible Association in 2025
In September 2025, the FDA announced that it had initiated a process for an acetaminophen label change to reflect evidence suggesting that use during pregnancy may be associated with an increased risk of neurological conditions, including autism and ADHD. The agency’s language was cautious. It discussed a possible association rather than stating that acetaminophen had been proven to cause either condition. The announcement intensified public attention but did not resolve the scientific dispute. Medical organizations and researchers continued to disagree about how the available studies should be interpreted.
Why Expert Testimony Matters
A family bringing a product liability lawsuit must generally prove more than the existence of studies reporting an association. Plaintiffs typically rely on qualified experts to address two separate questions:
- General causation: Is prenatal acetaminophen exposure capable of causing autism or ADHD?
- Specific causation: Did the alleged exposure contribute to this particular child’s condition?
The general-causation issue has dominated the federal litigation. Defendants argue that the research does not support a reliable causal conclusion. Plaintiffs argue that their experts used accepted scientific methodologies to interpret the overall body of evidence. This disagreement sits at the center of the litigation and will continue to be contested as the cases move forward. Scientific studies alone do not decide lawsuits. Courts must also determine whether the experts interpreting those studies satisfy the legal standards for admissibility.
What Is the Current Status of the Tylenol Autism Litigation?
Short Answer: The federal litigation remains active after the Second Circuit revived more than 500 lawsuits on July 13, 2026. The appellate court held that the district court improperly excluded testimony from three plaintiffs’ general-causation experts, but it did not decide that acetaminophen causes autism or ADHD. The federal lawsuits were centralized in the Southern District of New York as In re Acetaminophen – ASD-ADHD Products Liability Litigation, MDL No. 3043. The plaintiffs allege that children developed autism, ADHD, or both following acetaminophen exposure in utero.
The District Court Excluded the Plaintiffs’ Experts
The federal cases faced a major setback when the district court excluded the plaintiffs’ general-causation experts. Without admissible expert testimony supporting the proposition that prenatal acetaminophen exposure is capable of causing autism or ADHD, the plaintiffs could not establish an essential element of their claims. The ruling led to the dismissal of hundreds of cases. The plaintiffs appealed.
The Second Circuit Revived More Than 500 Claims
On July 13, 2026, a unanimous three-judge panel of the Second Circuit reversed the exclusion of testimony from three plaintiffs’ experts. The appellate court concluded that the district court had applied the wrong legal standard and had improperly substituted its assessment of the scientific evidence for the role of the factfinder. The panel determined that the experts’ methodologies reflected approaches used by other scientists and represented permissible interpretations of scientific evidence on which qualified scientists may disagree. The ruling revived more than 500 claims and returned the litigation to the district court for further proceedings.
What the Second Circuit Did NOT Decide
The appellate court did not decide that:
- Tylenol causes autism
- Acetaminophen causes ADHD
- The plaintiffs’ experts are necessarily correct
- Every pending claim is valid
- The defendants are liable
- Any family is entitled to compensation
The decision addressed whether the experts’ opinions were admissible under the governing evidentiary standard. It did not resolve the underlying causation question.
Can the Experts Still Be Challenged?
Yes. Allowing an expert to testify does not make the expert’s conclusions immune from challenge. Defendants can contest the opinions through:
- Cross-examination
- Competing expert testimony
- Challenges to the experts’ assumptions
- Criticism of individual studies
- Alternative explanations for the reported associations
- Arguments concerning the weight the jury should give the testimony
Kenvue has stated that it intends to continue challenging the reliability of the plaintiffs’ expert opinions.
Are There Any Tylenol Autism Settlements?
There is no announced global settlement resolving the Tylenol autism and ADHD litigation. Future settlements are possible, but they are not guaranteed. The cases must first proceed through additional discovery, expert challenges, dispositive motions, potential trials, or negotiations. It would be premature to assign reliable average settlement values while liability, causation, and case-selection standards remain contested. ANS can review your potential claim even while the litigation continues. Speaking with an attorney does not require you to follow every procedural development or determine for yourself what the appellate decision means. The litigation is moving forward, but eligibility still depends on the medical, factual, and legal circumstances of each family.
Tylenol Autism and ADHD Lawsuit Timeline
Short Answer: The litigation developed from years of scientific research, expanded into a federal MDL in 2022, suffered a major dismissal after the plaintiffs’ experts were excluded, and was revived by the Second Circuit in July 2026.
2021: Researchers Publish a Consensus Statement
Scientists and clinicians publish a consensus statement calling for precautionary acetaminophen use during pregnancy and further investigation into possible developmental risks.
2022: Federal Lawsuits Are Centralized
Federal acetaminophen autism and ADHD lawsuits are consolidated in the Southern District of New York as MDL No. 3043.
2023–2024: General Causation Becomes the Central Issue
The parties submit expert testimony addressing whether prenatal acetaminophen exposure is capable of causing autism or ADHD.
2024: The District Court Excludes Plaintiffs’ Experts
The district court excludes the plaintiffs’ general-causation experts, leading to the dismissal of hundreds of federal claims.
September 2025: FDA Addresses a Possible Association
The FDA announces that it has initiated a process intended to revise acetaminophen labeling to reflect evidence suggesting a possible association with autism and ADHD, while stopping short of declaring that causation has been established.
July 13, 2026: Second Circuit Revives the Litigation
The Second Circuit reverses the exclusion of three plaintiffs’ experts and revives more than 500 lawsuits.
Current Status
The cases return to the district court for further proceedings. The parties may continue litigating expert issues, case-specific causation, liability, and other legal questions. With that history in mind, the next question is whether an individual family may have a potential claim.
Who May Qualify to File a Tylenol Autism or ADHD Lawsuit?
Short Answer: A family may have a potential claim if the mother used Tylenol or another acetaminophen-containing medication during pregnancy and the child was later diagnosed with autism, ADHD, or both. However, those two facts alone do not establish a viable lawsuit. Attorneys must evaluate each potential case individually. Relevant considerations may include the timing, duration, and frequency of acetaminophen use, the child’s diagnosis, available records, other possible causes, and the law governing the claim.
Potential Claim Checklist
A case may deserve a closer look when several of the following are true:
- The mother used Tylenol or another acetaminophen-containing medication during pregnancy.
- The exposure occurred during a potentially relevant stage of pregnancy.
- Acetaminophen was used repeatedly, frequently, or over an extended period.
- The child was diagnosed with autism spectrum disorder, ADHD, or both.
- Medical records document the child’s diagnosis and treatment history.
- Prenatal, pharmacy, or purchase records may help document exposure.
- The claim is still within the applicable filing deadline.
- The family is willing to authorize a detailed medical and legal review.
This is not a definitive eligibility checklist. A family may lack receipts or remember only part of the exposure history and still have information worth reviewing.
Prenatal Acetaminophen Exposure
An attorney will generally ask:
- Why was acetaminophen taken?
- During which trimester or trimesters was it used?
- How often was it taken?
- What dosage was used?
- Was the medication recommended by a healthcare provider?
- Were other medications used during the pregnancy?
Exact recall is not always possible, particularly when the pregnancy occurred many years ago. Medical records, pharmacy histories, loyalty accounts, witness statements, and other information may help reconstruct what occurred.
A Documented Autism or ADHD Diagnosis
A formal diagnosis is usually an important part of the claim. An unconfirmed concern or isolated symptom generally is not enough on its own. Relevant documentation may come from:
- Pediatricians
- Developmental specialists
- Psychologists
- Psychiatrists
- Neurologists
- Schools
- Therapy providers
The timing of the diagnosis and the child’s developmental history may also affect the evaluation.
Other Potential Causes
Specific causation requires an analysis of the individual child’s circumstances. Attorneys and experts may consider:
- Genetics
- Family medical history
- Pregnancy complications
- Maternal infections or fever
- Premature birth
- Environmental exposures
- Other medications
- Additional developmental risk factors.
The existence of another risk factor does not automatically eliminate a claim. It may, however, affect how experts assess causation.
Filing Deadlines
Every state imposes deadlines for bringing product liability claims. The applicable period may depend on where the case is filed, when the child was diagnosed, when the family reasonably could have discovered a potential connection, the child’s age, and other state-specific rules. Families should not assume that they have unlimited time simply because the federal litigation remains active. If your family meets the basic exposure and diagnosis criteria, ANS can investigate the additional factors and determine whether a claim may be appropriate. The consultation is free. Once a potential claim has been identified, documentation becomes essential to evaluating and supporting it.
What Evidence Can Support a Tylenol Autism or ADHD Claim?
Short Answer: Important evidence may include prenatal medical records, pharmacy information, purchase histories, the child’s diagnostic records, treatment documentation, and evidence addressing other possible causes. A successful claim generally requires more than proof that acetaminophen was used during pregnancy and a diagnosis later occurred. The precise evidence needed depends on the law governing the claim and the facts of the individual case.
Evidence of Prenatal Acetaminophen Use
Helpful records may include:
- Prenatal medical records
- Obstetric records
- Primary care records
- Hospital or urgent care records
- Prescription histories
- Pharmacy account records
- Retail loyalty account histories
- Purchase receipts
- Insurance claims
- Messages discussing medication use
- Statements from family members or others with personal knowledge
Tylenol is available over the counter, so many consumers will not have a prescription record. The absence of receipts does not necessarily end the investigation. An attorney may be able to identify other records showing why acetaminophen was used, when it was recommended, or how frequently the mother experienced the condition for which it was taken.
Evidence of the Child’s Diagnosis
Relevant records may include:
- Autism or ADHD diagnostic evaluations
- Pediatric records
- Neurological or psychological testing
- Behavioral assessments
- Therapy records
- Individualized Education Programs
- School evaluations
- Prescription records
- Treatment plans
- Records documenting developmental milestones
These documents may establish the diagnosis, its timing, its severity, and the services the child requires.
Evidence of Damages
A legal team may also collect information showing how the condition affects the child and family. Examples include:
- Medical bills
- Therapy costs
- Educational expenses
- Transportation expenses
- Caregiving needs
- Employment records
- Expert life-care projections
- Evidence of future medical or supportive services
Evidence Addressing Alternative Causes
Defendants may argue that genetics, family history, maternal illness, fever, or other factors better explain the diagnosis. For that reason, attorneys may review records that initially seem unrelated to acetaminophen use. A complete medical history allows qualified experts to evaluate the case rather than ignoring information that could later become important. Do not delay contacting an attorney merely because some records are missing. ANS can help determine which documents are likely to exist, request appropriate records, and evaluate alternative ways to document the claim. Once the records are gathered, the next question is what losses the claim may cover.
You can contact ANS Lawyers here.
What Compensation May Be Available?
Short Answer: If a family successfully establishes liability and causation, compensation may include past and future medical expenses, therapy, educational support, lost earning capacity, caregiving costs, and certain non-economic damages. The available categories and amount depend on state law and the individual evidence. There is no guaranteed settlement amount for a Tylenol autism or ADHD claim. No global settlement currently provides a reliable valuation framework for individual cases.
Medical and Treatment Expenses
Recoverable economic damages may include the reasonable cost of:
- Medical appointments
- Diagnostic evaluations
- Behavioral therapy
- Occupational therapy
- Speech therapy
- Mental health treatment
- Prescription medications
- Assistive technology
- Transportation for treatment
- Other medically necessary services
Both past expenses and reasonably anticipated future costs may be relevant.
Educational and Support Services
Some children require services beyond traditional medical treatment. Potential expenses may include:
- Specialized educational programs
- Tutoring
- Vocational support
- Behavioral aides
- In-home services
- Adaptive equipment
- Independent living assistance
Whether a particular expense is recoverable depends on the evidence and applicable law.
Future Care Needs
Children with significant support needs may require assistance into adulthood. Attorneys may work with medical experts, vocational specialists, economists, or life-care planners to estimate:
- Future treatment costs
- Long-term therapy
- Supervision and caregiving
- Residential support
- Transportation
- Lost earning capacity
- Other anticipated needs
Lost Income and Earning Capacity
A parent may lose income because of medical appointments, caregiving responsibilities, or a reduced work schedule. A claim may also address the child’s diminished future earning capacity when supported by appropriate evidence. The method of calculating these losses varies by jurisdiction.
Non-Economic Damages
Depending on state law and the claims asserted, families may also seek compensation for non-economic losses. These may include:
- Pain and suffering
- Emotional distress
- Loss of enjoyment of life
- Disability-related limitations
- Other legally recognized harms
No attorney can responsibly predict an individual's recovery in a defective product claim or any personal injury claim in general before they’ve reviewed the evidence.
ANS can explain which damages may apply and how those losses would need to be documented. Recovering compensation requires a carefully developed claim, which is one reason early legal review can make a meaningful difference.
Why Should You Contact an Attorney Early?
Short Answer: Contacting an attorney early gives the legal team more time to investigate acetaminophen exposure, preserve records, evaluate filing deadlines, and address alternative causes. Waiting may make documents harder to obtain and could jeopardize the claim under an applicable statute of limitations. Early representation does not mean that a lawsuit must be filed immediately. It allows the attorneys to determine what should happen next.
Preserve Important Evidence
Medical providers, pharmacies, retailers, schools, and insurers do not necessarily retain records forever. Beginning early may help preserve:
- Prenatal records
- Pharmacy histories
- Retail account information
- Diagnostic records
- Therapy documentation
- Witness recollections
- Employment and financial records The longer a family waits, the greater the possibility that records will be deleted, archived, or otherwise become difficult to obtain.
Determine the Filing Deadline
Product liability filing deadlines vary by state and may involve complicated discovery rules, tolling provisions, or rules concerning minors. An attorney can identify the potentially applicable jurisdiction and evaluate the deadline based on the family’s circumstances. Relying on a general deadline found online can be dangerous because small factual differences may change the analysis.
Evaluate the Claim Before Standards Change
Mass tort cases can change quickly. Court rulings may affect:
- Which expert opinions are admissible
- What evidence plaintiffs must produce
- Which defendants remain in the litigation
- How claims are organized
- Which cases are selected for further proceedings
- Whether settlement discussions occur Beginning the evaluation early gives the firm time to respond to those developments without rushing the investigation.
Coordinate a Complete Review
These cases involve both legal and medical questions. An attorney can organize the records, identify factual gaps, consult appropriate experts when necessary, and determine whether the evidence supports proceeding. ANS offers free consultations, so families can obtain an initial assessment without paying an upfront fee or committing to litigation. That makes the choice of law firm especially important.
Why Choose Altman Nussbaum Shunnarah Trial Attorneys?
Short Answer: Altman Nussbaum Shunnarah is a litigation-driven personal injury firm with experience handling complex claims and mass tort litigation throughout the United States. The firm has recovered more than $800 million for over 75,000 clients and offers free consultations. A Tylenol autism or ADHD claim is not a routine personal injury case. It requires careful review of medical records, scientific evidence, product liability law, causation, and the evolving federal litigation.
Experience With Complex Litigation
ANS represents injured clients in personal injury, wrongful death, and mass tort matters. The firm’s attorneys understand that claims against large manufacturers may involve extensive discovery, sophisticated defense teams, and contested expert testimony.
A Detailed Case Review
A meaningful case evaluation requires more than confirming that Tylenol was used and a child was diagnosed. The firm may need to review:
- The pregnancy history
- Timing and duration of acetaminophen use
- Medical reasons for taking the medication
- Diagnostic records
- Treatment and educational needs
- Other potential risk factors
- The law governing the claim
- Applicable filing deadlines That investigation allows the legal team to give the family an informed assessment rather than an early promise the evidence may not support.
Clear Communication and Next Steps
Families dealing with autism or ADHD may already be managing medical appointments, school concerns, therapy, and substantial caregiving responsibilities. ANS strives to make the intake and legal process understandable. After a consultation request is submitted, the firm describes its process as an immediate review, contact within 24 hours, and clear next steps.
No Upfront Attorney’s Fees
ANS handles personal injury matters on a contingency fee basis. Clients do not pay upfront attorney’s fees, and the firm is paid from a recovery if compensation is obtained. The exact terms will be stated in the written representation agreement.
Nationwide Representation
The Tylenol autism and ADHD litigation involves families and defendants across the country. ANS describes itself as a nationally recognized, litigation-driven firm representing clients in personal injury and mass tort matters throughout the United States. Contact Altman Nussbaum Shunnarah Trial Attorneys for a free case evaluation. The legal team can review your family’s circumstances, explain the current litigation, and determine whether further investigation is warranted. The answers below address several additional questions families may have before contacting the firm.
What Happens After You Contact ANS?
Short Answer: After you contact ANS, the firm conducts an initial review, speaks with you about the relevant facts, and explains the next steps. A lawsuit is filed only if the firm accepts the case, you choose to proceed, and filing is appropriate.
1. Free Consultation
You provide basic information about the pregnancy, acetaminophen use, the child’s diagnosis, and any records that may be available.
2. Preliminary Case Review
The legal team considers whether the potential claim meets the firm’s current screening criteria and whether additional investigation is appropriate.
3. Records and Exposure Investigation
With your authorization, the firm may obtain relevant prenatal, pharmacy, diagnostic, treatment, educational, and financial records.
4. Legal and Medical Evaluation
The attorneys evaluate the evidence, applicable state law, filing deadline, causation issues, and current litigation requirements.
5. Filing the Claim When Appropriate
If the firm accepts the case and you decide to proceed, the legal team prepares and files the appropriate claim or lawsuit. Submitting a consultation form does not obligate you to file a lawsuit. It simply begins the review needed to determine whether a claim may be available.
Frequently Asked Questions About Tylenol Autism and ADHD Lawsuits
Can I file a lawsuit if I used generic acetaminophen instead of Tylenol?
Potentially. Claims have involved Tylenol and store-brand products containing acetaminophen, but the manufacturer, retailer, product labeling, and applicable state law may affect the legal theory. An attorney must identify the specific product whenever possible.
Can I pursue a claim if I no longer have receipts?
You may still be able to pursue a claim without original receipts. Pharmacy histories, retail loyalty accounts, medical records, insurance records, household statements, and other evidence may help document prenatal acetaminophen use.
Can I file if my child is now an adult?
Possibly. The child’s current age does not by itself determine whether a claim is barred, but the statute of limitations and rules concerning minors vary by state. An attorney should evaluate the deadline promptly.
Does the July 2026 appellate ruling mean the plaintiffs proved their cases?
No. The Second Circuit ruled that three general-causation experts should not have been excluded under the standard applied by the district court. It did not decide that acetaminophen causes autism or ADHD or that any defendant is liable.
Do all autism and ADHD diagnoses qualify?
No. A diagnosis alone is not enough. A legal team must also investigate prenatal acetaminophen exposure, timing, documentation, other possible causes, filing deadlines, and the requirements of the governing law.
Can I file a claim if a doctor recommended Tylenol during pregnancy?
A healthcare provider’s recommendation does not necessarily prevent a product liability claim. These lawsuits generally focus on warnings supplied by manufacturers or sellers, but the medical reason for use and the advice received may still be relevant.
Can I file if acetaminophen was taken for a fever?
Possibly, but the fever and the condition causing it may be important to the causation analysis. Maternal illness and fever are potential confounding factors that experts may need to evaluate.
Is there a Tylenol autism lawsuit settlement?
There is currently no announced global settlement resolving these claims. The litigation returned to the district court after the July 13, 2026 appellate decision and remains subject to further proceedings.
How long will a Tylenol autism lawsuit take?
There is no reliable timeline. The litigation may involve additional expert challenges, discovery, motions, individual case review, trials, appeals, or settlement discussions before claims are resolved.
Will filing a lawsuit affect my child’s medical care or benefits?
Filing a lawsuit ordinarily does not change the child’s medical diagnosis or treatment plan. However, a recovery could affect eligibility for certain means-tested public benefits, so families receiving those benefits may need advice about settlement planning.
Should pregnant patients stop taking acetaminophen?
Medication decisions should be made with a qualified healthcare provider. The scientific evidence remains disputed, and untreated pain or fever may also create risks. This page provides information about litigation, not individualized medical advice.
Speak With a Tylenol Autism and ADHD Lawsuit Attorney
The Tylenol autism and ADHD litigation is active again after the Second Circuit revived more than 500 federal claims.
However, the appellate decision did not establish causation, and each potential case still requires an individualized review of prenatal exposure, diagnosis, medical history, available evidence, and state law.
If you used Tylenol or another acetaminophen-containing medication during pregnancy and your child was later diagnosed with autism, ADHD, or both, contact Altman Nussbaum Shunnarah Trial Attorneys.
We are a nationwide, well-respected law group that handles all personal injury practice areas, including one of our main specialties: large mass torts like the Tylenol Autism Lawsuit discussed in this article.
The consultation is free. You pay no upfront attorney’s fees, and the firm can explain whether your family’s circumstances warrant further investigation.
Request a Free Case Evaluation